Jan. 3 - 6, 2012

Older athletes slower but no less efficient
The Sydney Morning Herald (Australia)
...The study’s author, Dr. Karl B. Fields of the University of North Carolina at Chapel Hill School of Medicine, speculated that the normal muscle wear and tear ‘‘that occurs with training seems to take greater time to repair with ageing, and older runners continue running at a frequency similar to that of younger runners.’’

'Stop Sugarcoating' Child Obesity Ads Draw Controversy
"World News with Diane Sawyer" ABC
...It is part of a video and print campaign to combat childhood obesity in Georgia, which has one of the highest childhood obesity rates in the nation. But could the ads end up stigmatizing overweight kids instead of solving the problem? "Blaming the victim rarely helps," said Dr. Miriam Labbok, director of the Carolina Global Breastfeeding Institute at the University of North Carolina at Chapel Hill. "These children know they are fat and that they are ostracized already."

Roses and Raspberries (Editorial)
The Chapel Hill News
Roses to Dr. Myron S. Cohen, a UNC professor whose work on HIV was named 2011's biggest scientific breakthrough by the prestigious journal Science. Cohen, the director of the UNC Institute for Global Health and Infectious Diseases, is the principal investigator in a study that found that early treatment with antiviral drugs sharply cut the risk that infected patients will transmit HIV, the virus that causes AIDS. The discovery could dramatically slow the spread of the disease.

UNC hospitals using technology to detect sponges after surgery
WNCN-TV (NBC/Raleigh)
UNC hospitals are using new technology in their operating rooms that could prevent a serious medical mistake. Before the technology was implemented, nurses used to count sponges to make sure they were all out of the patient after surgery. However that practice wasn't always accurate.

1,500 state workers qualify for new health care service
The Triangle Business Journal
Some 1,500 state workers covered by the State Health Plan are eligible to use the new Carolina Advanced Health, a joint venture between Blue Cross and Blue Shield of North Carolina and UNC Health Care that's designed to treat the most chronically ill patients.

Trial herpes vaccine misses mark for protection in young women
An experimental herpes vaccine protected young women against only one of the two types of the sexually transmitted virus, dashing hopes for widespread use of the treatment, researchers reported in the latest issue of the New England Journal of Medicine. ...“I think this is the end of the vaccine,” said coauthor Dr. Peter A. Leone, an infectious disease specialist at the University of North Carolina, Chapel Hill. “It would be difficult to imagine marketing a vaccine that would only work against HSV1.”

Drug gives rats booze-guzzling superpowers
Science News
...If the compound proves to have similar effects in humans, it may offer a powerful way to combat alcohol’s dizzying effects, the dreaded hangover and even alcohol dependence. “I think it’s really pretty incredible that one study opens up avenues for so many angles,” says neuroscientist A. Leslie Morrow of the University of North Carolina School of Medicine in Chapel Hill.

UNC Doctor Leads Innovative Study On Herpes Vaccinations
WCHL 1360-AM (Chapel Hill)
A UNC doctor recently co-authored a study that might help physicians develop a cure for women genital herpes. UNC Professor of Medicine Peter Leone co-authored the study, which tested an experimental vaccine for the virus. He says even though the vaccine didn’t prevent women from acquiring the disease, it did work against a strain of the herpes virus known as HSV 1.

Test vaccine shows promise for less severe type of herpes
WRAL-TV (CBS/Raleigh)
A new study published in the New England Journal of Medicine suggests a test vaccine may help prevent one type of genital herpes, the most common sexually transmitted infection, affecting one in four women in the United States. Unfortunately, though, it's less severe type – HSV-1 herpes – which means it probably won't be put on the market, says Dr. Peter Leone, an epidemiologist at University of North Carolina in Chapel Hill.

Share This: